Biocon Limited — Updates, 09-01-2025: Press Release

Biocon Biologics Ltd will present at the upcoming 43rd Annual J.P. Morgan Healthcare Conference on January 16, 2025, in San Francisco. CEO Shreehas Tambe is set to highlight the company’s commitment to equitable healthcare access and showcase its expanding product range and global presence, serving over 5 million patients in more than 120 markets. The presentation emphasizes the company’s strong R&D capabilities, underscored by 10 approved biosimilars and a promising pipeline aligned with key therapeutic areas like oncology and immunology. This event marks a significant milestone, celebrating a year since the integration of their acquired biosimilars business, signaling an optimistic outlook with upcoming product launches and strategic market expansions. An audio webcast of the presentation will be available online, enhancing accessibility for investors and stakeholders.